Chlorpheniramine / Methscopolamine / Phenylephrine Dosage
Applies to the following strengths: 2 mg-0.625 mg-10 mg/5 mL; 8 mg-2.5 mg-20 mg; 2 mg-1.25 mg-10 mg/5 mL; 2 mg-1.25 mg-10 mg; 4 mg-1.25 mg-10 mg; 12 mg-2.5 mg-20 mg; ages 12 years and older; 2 mg-0.75 mg-8 mg/5 mL; 2 mg-0.75 mg-10 mg/5 mL; 4 mg-1.25 mg-10 mg/ 5 mL; 8 mg-1.25 mg-20 mg; 2 mg-1.5 mg-10 mg/5 mL; 8 mg-2.5 mg-25 mg; 2 mg-1.25 mg-15 mg; 2 mg-1.5 mg-10 mg; ages 6 years and older; 8 mg-2.5 mg-40 mg; 12 mg-2 mg-40 mg
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Nasal Congestion
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
Usual Adult Dose for Rhinitis
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
Usual Pediatric Dose for Nasal Congestion
12 yrs and older:
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
6 yrs to 11 yrs:
Liquid:
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily.
Chew tab:
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day.
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release:
1/2 tablet orally twice daily, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening.
Usual Pediatric Dose for Rhinitis
12 yrs and older:
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
6 yrs to 11 yrs:
Liquid:
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily.
Chew tab:
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day.
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release:
1/2 tablet orally twice daily, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dialysis
Data not available
More about chlorpheniramine / methscopolamine / phenylephrine
- Check interactions
- Compare alternatives
- Reviews (6)
- Drug images
- Side effects
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
See also:
Flonase
Flonase (fluticasone nasal) is used to treat nasal congestion, sneezing, and runny nose caused by ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Flonase Allergy Relief
Flonase Allergy Relief is used for allergic rhinitis, allergies, rhinitis
Levsin
Levsin is used to treat stomach problems such as cramps and irritable bowel syndrome and conditions ...
Sudafed Congestion
Sudafed is a decongestant and is used to treat nasal and sinus congestion. Learn about side ...
Xhance
Xhance (fluticasone propionate) is a corticosteroid nasal spray with a unique exhalation delivery ...
Hyosyne
Hyosyne is used for anticholinesterase poisoning, diverticulitis, irritable bowel syndrome ...
Oxymetazoline nasal
Oxymetazoline nasal is used for allergies, nasal congestion
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
